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There have been some reports of coincidental presentation of breast carcinoma and phyllodes tumor in the same
breast. Most of the cases were carcinoma that arose from a phyllodes tumor with a histologically identified
transitional area, and they behaved less aggressively than the usually encountered carcinoma. Collision tumors are
rare clinical entities in which two histologically distinct tumor types show involvement at the same site. The
occurrence of these tumors in the breast is extremely rare. Here, we report a case of 45-year-old woman who had
both invasive ductal carcinoma as the finding of inflammatory carcinoma and a malignant phyllodes tumor in the
same breast. There was no evidence of a transitional area between the phyllodes tumor and the invasive ductal
carcinoma. To our knowledge, this is the first report of a collision tumor of inflammatory breast carcinoma
coincident with a malignant phyllodes tumor in same breast.
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Collision tumors are rare clinical entities in which two his-
tologically distinct tumor types show involvement in the
same site. Coincidental occurrence of breast carcinoma
and axillary lymphoma has been reported with a variant
subtype of lymphoma and leukemia [1,2]. But, the presen-
tation of carcinoma and other tumors in same breast as a
finding of collision tumor is extremely rare, and there have
been few reports of collision tumor consisting of invasive
ductal carcinoma admixed with breast mucosa-associated
lymphoid tissue lymphoma [3], chronic lymphocytic
leukemia and lactating adenoma [4]. The epithelial com-
ponent of phyllodes tumors (PTs) can transform to carcin-
oma and the type of carcinoma that has been reported
varied and include in situ carcinoma invasive ductal, tubu-
lar, lobular and squamous carcinoma types [5-7]. These le-
sions reported in the literature showed a histologically
identified transitional area, and they behaved less aggres-
sively than the usually encountered carcinoma. The
present case of collision tumor, which consisted of PT and* Correspondence: yj0139@naver.com
2Department of Surgery, Eulji University Hospital, Eulji University School of
Medicine, Dunsan-dong 1306, Seo-gu, Daejeon 135-710, Korea
Full list of author information is available at the end of the article
© 2014 Shin et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orinvasive carcinoma in the same breast, is extremely rare;in
a review of the literature, we found three cases of collision
tumor with malignant PT and invasive carcinoma [8-10].
Here, we report a case of a 45-year-old woman who had
both malignant PT with invasive carcinoma as the finding
of inflammatory breast carcinoma with massive lymph
node (LN) involvement. There was no evidence of a defin-
ite transition between two types of tumor, the patient was
diagnosed as having a collision tumor with carcinoma and
malignant PT. To our knowledge, this is the first report of
a collision tumor of the breast that consisted of inflamma-
tory carcinoma and malignant PT.Case presentation
A 45-year old woman presented with a huge left breast
mass that had necrosis and a foul odor. She had a history
of contralateral metaplastic carcinoma, and she had
undergone a right modified radical mastectomy 15 years
previously. She also presented with a 2-cm-sized painless
palpable breast mass in her left breast two years before
presentation for the case in this report, but she did not
undergo any clinical work-up at that time. Then, approxi-
mately 2 or 3 months prior to presentation of this case,
she noticed a mass extrusion of the outside skin with rapidd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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20 cm in diameter was seen in the entire left breast. The
mass was extruded skin outside, and skin overlying the
mass was thickened with edematous change (Figure 1).
The axilla showed multiple conglomerated lymph nodes
(LNs) that were fixed to the chest wall.
A chest computerized tomography (CT) showed a 22-
cm-sized huge breast mass with necrotic changes and
multiple LN enlargements in the left axilla, both supracla-
vicular and parasternal areas including the left internal
mammary and paracardiac LNs (Figure 2a). On 18 F-FDG
positron emission tomography (PET)/CT, a huge uneven
hypermetabolic mass was seen in the left breast, and there
was no evidence of distant organ metastasis except for ex-
tensive hypermetabolic LN metastasis (Figure 2b).
Under strong clinical suspicion of inflammatory breast
cancer, we performed a core needle biopsy on the tumor it-
self. Core-cut biopsy revealed a biphasic neoplasm with
mild nuclear atypia and low mitotic activity, accompanied
by leaf-like processes protruding into dilated ductal spaces,
consistent with a low-grade phyllodes tumor. We discussed
the discrepancy about the clinical diagnosis and core bi-
opsy results at the preoperative multidisciplinary meeting
that included an oncologist, a breast surgeon, a pathologist
and a radiologist. We concluded the case was a carcinoma
associated with huge phyllodes tumor and decided not to
do further preoperative biopsy. The patient underwent a
palliative modified radical mastectomy with level II axillary
LN dissection. Macroscopic examination of the resection
specimen revealed a firm and well-demarcated mass with
hemorrhage and necrosis, measuring approximately 24 cm
in the largest dimension (Figure 3a). This mass was com-
posed of two separated tumorous lesions: phyllodes tumor
and invasive carcinoma of no special type. Histologically,
about 70% of the tumor area represented a classicalFigure 1 Bulky tumor mass with extensive necrosis and
ulceration was seen on left breast.phyllodes tumor showing variable benign to malignant
histologic characteristics. The malignant phyllodes tumor
was composed of highly cellular stromal cells, moderate
and variable nuclear atypia, and increased mitotic activity
(>10 mitotic figures per 10 high-power fields) (Figure 3b).
In addition, in almost one-third of the tumor, frankly inva-
sive carcinoma of no special type (Figure 3c) with foci of
pleomorphic carcinoma was observed (Figure 3d). The skin
was thickened and showed pathognomonic dermal lymph-
atic tumor emboli, consistent with inflammatory carcin-
oma (Figure 4a). The areas of margin between the two
tumor lesions were evaluated by further re-cutting and ser-
ial section. On serial section, there was no histologic evi-
dence of transition from phyllodes tumor to invasive
ductal carcinoma, so the lesion was thought to be a colli-
sion tumor with invasive carcinoma of no special type and
malignant PT, rather than ductal carcinoma arising from
PT (Figure 4b). Metastatic ductal adenocarcinoma cells
were detected in 16 out of 16 dissected axillary lymph
nodes. On immunohistochemistry, both epithelial and stro-
mal compartment of the PT as well as the carcinoma cells
showed no immunoreactivity for estrogen and progester-
one receptors and HER2, except for p53 overexpression on
the carcinoma cells.
The wound healed completely without complication.
Chemotherapy based on anthracyclines and taxanes was
started and radiotherapy was planned. Six months after
the operation, and after completion of eight cycle’s chemo-
therapy, the patient developed left supraclavicular and
upper chest wall swelling, which was consistent with
regional aggravation of metastatic carcinoma and was
supported by image findings. She underwent a session of
radiation therapy to the chest wall and neck, and
platinum-based chemotherapy will be pursued in this
patient as further treatment. She is doing well with good
compliance to the chemotherapy and radiation therapy.
Discussion
Although there have been some cases reported of coinci-
dental presentation of breast carcinoma and PT in same
breast, most of the cases were the carcinoma that arises-
from the epithelial component of a malignant or benign
PT [5-7]. On review of the literature, we found three cases
of true collision tumor with malignant PT and invasive
ductal carcinoma in the same breast (Table 1). In case 1
and case 2, collision tumors were composed of malignant
PT with sarcomatous differentiation and ductal carcinoma
in a separate manner [8,9]. But case 3 was a collision
tumor of ductal carcinoma within malignant PT without
transition. In case 3, a clonal examination was performed
to differentiate the tumor and an analysis of the poly-
morphic microsatellite markers revealed a divergent loss
of heterozygosity(LOH) pattern between stromal and epi-
thelial components of the PT and the carcinoma, thereby
Figure 2 Image findings. (a) Enhanced chest computed tomography (CT) showing a huge breast mass with necrosis and multiple lymph node
(LN) enlargements in the left axilla, both supraclavicular area. (b) 18 F-FDG positron emission tomography (PET)/CT revealed a huge uneven
hypermetabolic mass and massive hypermetabolic LN metastases without the evidence of distant organ metastasis.
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present case showed distinct presentation of the two sep-
arate tumors in same site without any interminglement. In
addition, the spindle cell lesion reveals strong expression
for vimentin and negative immunoreactivity for Pan-CK,Figure 3 Pathologic findings and photomicrographs of the rumor. (a)
mass which composed of two separated tumorous lesions; phyllodes tumo
with clearly defined margin (white thick arrows). (b) Malignant phyllodes tu
activity, resembling fibrosarcoma (original magnification × 400). (c) Area of
(d) Area with pleomorphic carcinoma (original magnification × 400).CK5/6, HM-CK, and the tumor cells in the axillary LNs
and skin lesions were compatible with those of invasive
ductal carcinoma. So, the lesion was identified as a collision
tumor with invasive ductal carcinoma and malignant PT,
rather than as a type of carcinosarcoma.Macroscopic examination of the left breast showed a well demarcated
r (red arrow) and invasive carcinoma of no special type (blue arrow)
mor showing a marked stromal cell proliferation with brisk mitotic
invasive carcinoma of no special type (original magnification × 400).
Figure 4 Photomicrographs of the tumor. (a) Thickened skin
showing dermal lymphatic tumor emboli (original magnification ×
100). (b) Collision tumor composed of phyllodes tumor and invasive
carcinoma of no special type (original magnification × 40).
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be a useful tool for the diagnosis of breast PT. PTs
showed internal non-enhanced septations, silt-like pat-
terns in enhanced images and signal changes from T2-
weighted to enhanced images correlated with the
histologic grade [11,12]. MRI showed findings typical
of ductal carcinoma, an irregular mass with segmental,
regional enhancement demonstrating a rapid increase
in signal intensity following contrast enhancement
followed by rapid washout. A preoperative MRI could
have elevated the diagnostic accuracy in the present
case, but we would have been unable to study an MRI
because of the huge mass. Also, although there were
some differences in metabolism in PET/CT image
between PT and ductal carcinoma, they were not path-
ognomonic. Unfortunately we could not distinguish PT
and ductal carcinoma in the preoperative CT and PET/
CT images because there was a wide area of necrosisin both the huge PT and in the inflammatory breast
carcinoma.
The clinical prognosis of collision tumor may be influ-
enced by the subtype and pathologic stage of the more
aggressive tumor in the breast. The prognosis for cases
consisting of carcinoma and benign PT may be favor-
able, however, when a carcinoma lesion is detected at an
early stage or as an in situ lesion due to a rapidly grow-
ing PT [6,7]. In our case, invasive carcinoma of no spe-
cial type may be considered to have a greater adverse
effect on clinical prognosis than the PT due to extensive
dermal lymphatic tumor emboli and metastatic ductal
carcinoma in the axillary lymph nodes. Furthermore, in-
vasive carcinoma showed triple negative breast cancer
(TNBC) with neither expressed hormonal receptors
noroverexpressed HER2. Chemotherapy is the only sys-
temic treatment available for TNBC. Cytotoxic therap-
ies, anthracyclines or taxanes, achieved good tumor
regression rates in the neo-adjuvant setting, but also
showed considerable recurrence. Platinum-containing
regimens should be considered as an important treat-
ment option for in both the neoadjuvant and metastatic
setting [13]. Even though inflammatory breast carcin-
oma is often considered a systemic disease, the risk for
locoregional recurrence remains an important clinical
problem, particularly for patients with triple negative
inflammatory breast carcinoma. Therefore, locoregio-
nal treatment intensification should be considered on
an individual basis. After completion of anthracyclin-
and taxane-based chemotherapy, our patient showed
left upper chest wall and supraclavicular swelling, con-
sistent with regional aggravation of metastatic carcin-
oma. After the completion of radiation therapy to the
chest wall and neck, platinium-based chemotherapy
is scheduled.Conclusions
We reported a rare case of a collision tumor presented
as inflammatory breast carcinoma of a ductal adeno-
carcinoma and malignant PT. Lacking standardization,
treatment of these extremely rare cases should there-
fore be tailored to treat PT and carcinoma individually.
A multimodal approach, including an extensive surgery
that includes axilla, may be warranted, as well as
an adjuvant treatment with radiation therapy and
chemotherapy.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Table 1 Summary of reported cases of collision tumor with breast phyllodes tumor and invasive ductal carcinoma
No. Author [Reference] Year Age PT IDC Site Surgery Treatment Outcome F/U period (mo.)
Type Size (cm) LNI T stage Size (cm) N stage
1 L. Auerbach [8] 2002 69 M (−) T1b N1 Separate site PM AD ET (TAM) LR of PT in 40 mo. 51.
Died of lung metastasis of PT
2 Kefeli M et al. [9] 2008 26 M 4.5 (−) T2 2.5 N1 (1/22) Separate site MRM CT RT Died in 1 year 12
3 Macher-Goeppinger S et al. [10] 2010 70 M 6 (−) T2 2.5 N0 Same site MRM CT RT F/u loss
4a Shin YD et al. 2013 45 M 24 (−) T4d 8 N3c (16/16) Same site MRM CT RT Local recurrence of IDC in 6 mo. 14
aPresent case.
AD, axillary dissection; CT, chemotherapy; ET, endocrine therapy; F/U, follow up; IDC, invasive ductal carcinoma; LNI, lymph node involvement; LR, local recurrence; M, malignant; MRM, modified radical mastectomy;
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